![Sekar Kathiresan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sekar Kathiresan
Direktor/Vorstandsmitglied bei
RELAY THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 31.05.2026
Profil
Sekar Kathiresan was the founder of Verve Therapeutics, Inc., founded in 2018, where the title held was Chief Executive Officer & Director.
Dr. Kathiresan was the founder of Maze Therapeutics, Inc., founded in 2017, with the title of Independent Director from 2022 to 2025.
The current job is Independent Director at Relay Therapeutics, Inc. starting in 2022.
Former jobs include Director at Center for Genomic Medicine Massachusetts General Hospital from 2016 to 2019, Director-Cardiovascular Disease Initiative at The Broad Institute, Inc. from 2014 to 2019, Assistant Physician at The General Hospital Corp.
from 1997 to 2021, and Professor at Harvard Medical School from 2018 to 2021.
Education includes undergraduate degree from the University of Pennsylvania and doctorate from Harvard Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases 0,19 % | 22.09.2025 | 103.723 ( 0,19 % ) | 3 Mio $ | 31.05.2026 |
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Sekar Kathiresan
| Unternehmen | Position | Beginn |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 25.07.2022 |
Ehemalige bekannte Positionen von Sekar Kathiresan
| Unternehmen | Position | Ende |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Gründer | 01.11.2025 |
| VERE THER | Gründer | 25.07.2025 |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Corporate Officer/Principal | 01.08.2021 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.06.2021 |
Center for Genomic Medicine Massachusetts General Hospital | Direktor/Vorstandsmitglied | 01.06.2019 |
Ausbildung von Sekar Kathiresan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Center for Genomic Medicine Massachusetts General Hospital |
